Every organ transplant is a modern medical feat. Only the transplant surgeon transports life from one to another. Only the organ donor offers such a second chance.
But the chronic supply-demand imbalance of donor organs challenges the system and limits the access and the impact. The transplantation community hungers for new ideas and new technologies to push the boundaries and redefine what’s possible.
Meanwhile regenerative medicine promises an endless supply of manufactured organs. Lab-grown. Bioprinted. Cryobanked. Transgenic. But the journey from bench to bedside needs a new kind of donor. A machine to deliver the wholly functional organ. And Tevosol will be there.